Challenges of Regulated Cell Death: Implications for Therapy Resistance in Cancer

Maria D'Amico1, Francesca De Amicis1,2

  • 1Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy.

Cells
|July 12, 2024
PubMed

Insights

Targeting regulated cell death pathways, including apoptosis and autophagy, offers new therapeutic strategies for cancer. Understanding these cell death mechanisms is crucial for overcoming therapy resistance and improving patient outcomes.

Area of Science:

  • Oncology
  • Cell Biology

Background:

  • Regulated cell death is vital for organismal homeostasis, with dysregulation implicated in cancer development.
  • Altered cell death pathways have complex and varied effects on cancer cells, presenting therapeutic opportunities.
  • Targeting cell death mechanisms with small molecules is a promising strategy in cancer therapy.

Purpose of the Study:

  • To review key signaling pathways in apoptotic and autophagy-dependent cell death.
  • To explore other regulated cell death pathways relevant to cancer.
  • To discuss current understanding and implications for cancer treatment, focusing on overcoming resistance.

Main Methods:

  • Literature review of signaling pathways in regulated cell death.
  • Analysis of the role of apoptosis, autophagy, and other cell death modes in cancer.
  • Synthesis of information on therapeutic strategies and resistance mechanisms.

Main Results:

  • Key signaling pathways for apoptosis and autophagy-dependent cell death are summarized.
  • Other regulated cell death pathways in cancer are explored.
  • Current therapeutic approaches targeting cell death are discussed in relation to resistance.

Conclusions:

  • Understanding regulated cell death pathways is essential for developing novel cancer therapies.
  • Targeting apoptosis and autophagy can offer strategies to combat cancer therapy resistance.
  • Further research into diverse cell death mechanisms can enhance overall cancer treatment efficacy.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K